Engineering anti-cancer nanovaccine based on antigen cross-presentation
10.1042/BSR20193220
Saved in:
Main Authors: | Warrier, V.U., Makandar, A.I., Garg, M., Sethi, G., Kant, R., Pal, J.K., Yuba, E., Gupta, R.K. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Review |
Published: |
Portland Press Ltd
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/209926 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
by: Ni, Q, et al.
Published: (2022) -
Activated Brain Endothelial Cells Cross-Present Malaria Antigen
by: Howland S.W., et al.
Published: (2020) -
A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice
by: Taweewun Hunsawong, et al.
Published: (2018) -
A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
by: Chang, Mengyu, et al.
Published: (2024) -
Regulation of antigen presentation in dendritic cells
by: HUANG DACHUAN
Published: (2010)